Reprogramming-driven Proteomic Shifts Mirror Bladder Cancer Progression and Reveal Biomarker Candidates Across Disease Grades.

Cancer Genomics Proteomics · 2026 · PMC13321705 · PMID 42373219

Europe PMC DOI

hedged sentence

0.3940

closest p · 7.9× alpha

0.3940

boldest claim

The sentences

a favorable trendp =0.394not close (p > 0.1)

PPP2R2A (F=0.416, p =0.66) also showed a favorable trend, whereas PTPN11 (SHP2) (F=9.33, p =0.394) was associated with shorter survival, consistent with its oncogenic role in RAS/MAPK and PI3K/AKT signaling ( 50 , 51 ).

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.